Should people have affordable access to “designer drugs” or experimental treatments through their commercial insurance? If your answer is yes then what is your position for those on Medicare or Medicaid where it is not covered? How would you address that patient need?
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|
